Health Canada has granted a Notice of Compliance with conditions (NOC/c) for Tagrisso® (osimertinib) for the treatment of patients with locally advanced, unresectable (stage III) non-small cell lung ...

13.5 months with anastrozole alone; hazard ratio for progression or death, 0.80; P=0.007) in a prospective, randomized clinical trial (S0226). 1 The incidence of severe toxic effects was similar ...

Understanding the relationship between the structure of a tornado-like vortex and how it transports debris can help curb its ...

BACKGROUND: Desmosomal gene variants (DGVs) have been associated with a diverse spectrum of phenotypic manifestations within ...

Positive recommendation based on phase III INAVO120 data showing ItovebiTM (inavolisib) in combination with palbociclib and ...

Acting Chair Travis Hill suggested the agency use total liabilities rather than insured deposits as the denominator in the ...

WASHINGTON (Reuters) -The U.S. Federal Aviation Administration on Thursday said it approved SpaceX's Starship to return to flight after its explosive test failure in March, allowing Elon Musk's ...

The secondary composite outcome occurred in 350 patients (9.5%) in the finerenone group and in 395 (10.8%) in the placebo group (hazard ratio, 0.87; 95% CI, 0.76 to 1.01). The overall frequency of ...

The S&P 500 pulled back 2% during the first four trading sessions this week, but it was essentially flat for 2025 through May 22, with dividends reinvested. So some investors might still have been ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...